Illustration: Maura Losch/Axios
Cohere Health, which automates the prior authorization process for health care providers, is targeting a $50 million to $100 million Series C in mid-2024, CEO Siva Namasivayam tells Axios exclusively at HLTH in Las Vegas.
Why it matters: Prior authorization technology — sometimes referred to as the holy grail use case for AI in health care — has drawn significant investor interest.
